Autologous ex vivo activated NK cell infusion

autologous ex vivo activated natural killer (NK) cell therapy · National University Hospital, Singapore

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous ex vivo activated NK cell infusion, covering 2010-04-09 to 2010-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma [Phase 1]

See pricing